Profile
ALVO ZTS TAK HLN TEVA NBIX
Company Name Alvotech Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $3.75B $77.92B $43.43B $43.25B $20.24B $15.52B
Employees 1.00K 14.10K 49.28K 25.41K 37.00K 1.70K
CEO Mr. Robert Wessman Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Mr. Kyle W. Gano Ph.D.
Ratings
ALVO ZTS TAK HLN TEVA NBIX
Quant Rating Score 1 3 3 3 1 4
Quant Rating Strong Sell Neutral Neutral Neutral Strong Sell Buy
Trading
ALVO ZTS TAK HLN TEVA NBIX
Last Close $12.41 $172.71 $13.7 $9.57 $17.84 $153.29
High 52 $17.27 $199.94 $15.08 $10.69 $22.77 $153.29
Low 52 $10.76 $145.54 $12.6 $8.01 $12.01 $111.62
Price vs. 52 Week High -28.14 % -13.62 % -9.15 % -10.48 % -21.65 % 0 %
Price vs. 52 Week Low 15.33 % 18.67 % 8.73 % 19.48 % 48.54 % 37.33 %
Total Return
ALVO ZTS TAK HLN TEVA NBIX
1 Month Return -6.2 % 6 % 3.47 % 0.31 % -19.06 % 12.3 %
3 Month Return -4.39 % -3.4 % -1.72 % -1.24 % -3.25 % 27.45 %
6 Month Return 6.07 % -4.07 % -1.3 % 4.59 % 2.35 % 8.28 %
9 Month Return -14.3 % 8.97 % 3.87 % 14.61 % 27.61 % 7.17 %
YTD Return -6.2 % 6 % 3.47 % 0.31 % -19.06 % 12.3 %
1 Year Return -21.21 % -8.04 % -6.16 % 16.71 % 47.44 % 9.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVO ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.04 % 4.56 % 1.65 % - -
Dividend Paid and Capex Coverage Ration (TTM) -7.27 % 2.1 % 1.34 % - 3.8 % 13.12 %
Dividend Per Share (TTM) - 1.8 % 192 % 0.06 % - -
Payout Ratio (TTM) - 31.44 % 101.62 % - - -
Growth
ALVO ZTS TAK HLN TEVA NBIX
Asset Growth 14.68 % -4.28 % 8.25 % -2.18 % -1.2 % 37.27 %
Gross Profit Growth -466.65 % 3.7 % 1.76 % 5.84 % 9.65 % 26.06 %
Revenue Growth 10.12 % 5.74 % 5.87 % 4.09 % 6.17 % 26.76 %
Revenue 3 Year -81.13 % 31.98 % 33.13 % 13.9 % -6.91 % 71.93 %
Revenue 5 Year 207.13 % 53.64 % 103.83 % 32.87 % -23.33 % 308.36 %
Revenue 10 Year 207.13 % 103.1 % 152.69 % 32.87 % -40.82 % 44100.16 %
EBIT Growth -2.43 % 6.27 % -56.36 % 9.37 % -84.52 % 0.76 %
Net Income Growth -7.43 % 10.88 % -54.56 % -1.04 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share 55.38 % 47.55 % -61.74 % -8.67 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share -181.85 % 71.94 % 32.36 % 59.66 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share -181.85 % 404.24 % 35.42 % 59.66 % -133.42 % 470.4 %
Operating Income Growth -2.43 % 6.27 % -56.36 % 9.37 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) 0.07 % 23.06 % -26.69 % 1.79 % -13.96 % 14.88 %
Operating 3 Year CFG 42.22 % 14.12 % -29.25 % 48.8 % 10.09 % 62.6 %
Operating 5 Year CFG -277.99 % 37.69 % 118.64 % 166.36 % -48.98 % 275.6 %
Operating 10 Year CFG -277.99 % 274.61 % 384.17 % 166.36 % -67.94 % 1000.37 %
EPS Growth 6.54 % 12.64 % -54.92 % - 76.42 % 59.01 %
EPS Diluted Growth 6.54 % 12.92 % -54.86 % - 76.42 % 58.33 %
Book Value Per Share -43.74 % 15.25 % 13.54 % 1.35 % -7.25 % 28.15 %
Share Holder 3 Year Equity Growth Per Share 85.21 % 36.7 % 40.38 % -36.6 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share - 139.55 % 41.33 % -39.41 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share - 476.36 % 195.14 % -39.41 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % 1.95 % -85.58 % - -
Dividend 3 Year Growth Per Share - 87.76 % 1.19 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % 101.42 % -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 102.58 % -66.42 % -100 % -
Debt Growth 33.58 % -16.5 % 10.53 % -9.43 % -6.53 % 62.95 %
Free Cash Flow Growth 0.76 % 22.25 % -31.4 % 1.67 % -19.19 % 11.99 %
Updated On 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
ALVO ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 56.08 % 68.87 % 55.23 % 60.68 % 49.84 % 98 %
Return on Assets TTM -35.8 % 16.93 % 1.99 % 3.26 % -2.38 % 10.92 %
Return on Equity TTM 69.49 % 47.99 % 4.04 % 6.54 % -14.6 % 15.68 %
Return on Capital Employed TTM -4.24 % 26.36 % 4.18 % 7.22 % 1.6 % 18.91 %
Net Income Per EBT TTM 91.6 % 79.65 % 108.74 % 65.38 % 176.38 % 73.98 %
EBT Per Ebit TTM 1060.5 % 91.46 % 52.35 % 82.95 % -125.67 % 88.81 %
EBIT Per Revenue TTM -12.37 % 36.45 % 11.21 % 17.82 % 2.67 % 26.19 %
Cash Flow To Debt Ratio TTM -22.43 % 43.6 % 16.58 % - 9.63 % 189.5 %
Receivables Turnover TTM 2.52 6.49 6.3 5.27 4.84 4.66
Payables Turnover TTM 2.8 7.05 4.92 1.23 3.55 0.47
Inventory Turnover TTM 1.29 1.18 1.69 3.03 2.12 0.98
Fixed Asset Turnover TTM 89.87 % 259.93 % 240.84 % 604.62 % 277.85 % 664.93 %
Asset Turnover TTM 29.8 % 63.75 % 31.2 % 33.71 % 40.16 % 63.45 %
Operating Cash Flow Per Share TTM -1 6.5 528.88 - 1.64 4.71
Free Cash Flow Per Share TTM -1.14 5.1 321.24 - 1.21 4.35
Cash Per Share TTM 44.78 % 378.45 % 57241.03 % 5.72 % 292.94 % 1214.64 %
Operating Cash Flow Sales Ratio TTM -72.06 % 32.18 % 18.42 % - 11.07 % 21.24 %
Free Cash Flow Operating Cash Flow Ratio TTM 113.75 % 78.37 % 60.74 % - 73.71 % 92.38 %
Cash Flow Coverage Ratios TTM -22.43 % 43.6 % 16.58 % - 9.63 % 189.5 %
Price To Free Cash Flows Ratio TTM -12.46 33.76 13.12 - 14.86 35.27
Price To Operating Cash Flows Ratio TTM -12.42 26.56 7.96 - 10.94 32.53
Price Cash Flow Ratio TTM -12.42 26.56 7.96 - 10.94 32.53
Income Statement (TTM)
ALVO ZTS TAK HLN TEVA NBIX
Revenue $0.09B $8.54B $4263.76B $11.3B $16.54B $1.89B
Gross Profit $-0.07B $5.83B $2832.26B $6.96B $8.06B $1.85B
Gross Profit Ratio -75.93% 68.28% 66.43% 61.59% 48.74% 97.9%
EBITDA $-0.48B $3.69B $874.6B $2.35B $-0.3B $0.36B
Net Income $-0.55B $2.34B $144.07B $1.05B $-1.64B $0.25B
EPS Diluted -2.43 5.07 91.16 0.11 -1.43 2.47
Balance Sheet (MRQ)
ALVO ZTS TAK HLN TEVA NBIX
Long Term Debt $1.03B $6.75B $5029.93B $8.8B $18.48B $0.26B
Total Liabilities $1.88B $9.3B $7834.79B $17.33B $35.35B $1.02B
Total Equity $-0.93B $4.99B $7274.01B $16.73B $8.13B $2.23B
Total Investments $0.02B $0.02B $445.7B $0.07B $0.01B $1.63B
Total Debt $1.08B $6.76B $4843.75B $9.46B $20.15B $0.43B
Total Assets $0.95B $14.29B $15108.79B $34.06B $43.48B $3.25B
Cash Flow Statement (TTM)
ALVO ZTS TAK HLN TEVA NBIX
Net Income $-0.55B $2.34B $144.07B $1.11B $-1.96B $0.25B
Inventory $-0.01B $-0.36B $-115.74B $-0.13B $0B $0.01B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $-0.31B $2.35B $716.34B $2.1B $1.25B $0.39B
Capital Expenditure $-0.05B $-0.73B $-480.73B $-0.34B $-0.5B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.82
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.57
ALIM Alimera Sciences, Inc. 5.54
ALVOW Alvotech 2.48
AMPH Amphastar Pharmaceuticals, Inc. 36.37
AMRX Amneal Pharmaceuticals, Inc. 8.58
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 59.56
AQST Aquestive Therapeutics, Inc. 3.08
ASRT Assertio Holdings, Inc. 0.8255
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 7.69
AYTU Aytu BioPharma, Inc. 1.68
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ALVO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.01 44.82
IBB iShares Biotechnology ETF 0.13505 138.87
VEU Vanguard FTSE All-World ex-US Index Fund 0 59.93
VT Vanguard Total World Stock Index Fund 0 121.94
VXUS Vanguard Total Intl Stock Idx Fund 0 61.53
SCHE Schwab Emerging Markets Equity ETF 0.0115551 27.25
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 77.52
DWAS Invesco DWA SmallCap Momentum ETF 0.199 93.84
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.12 27.58
SPAK Defiance Next Gen SPAC Derived ETF 0.14 14.63
IBBQ Invesco Nasdaq Biotechnology ETF 0.325 22.65
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.32398 6.5925
VTSNX Vanguard Total Intl Stock Idx Fund 0 132.06
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.32398 6.5915
STXK Ea Series Trust - Strive 2000 ETF 0.05 32.4858
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 37.28
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.01 37.12
VTIAX Vanguard Total International Stock Index Fd Admiral 0 33.02
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 43.21
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.01 93.9
VTWIX Vanguard Total World Stock Index I 0 249.1
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 132.09
RFLR Innovator ETFs Trust 0.06 26.2533
Unlock